Home › Forums › Main Forum › FixHepC Admin › Q & A › Prof Gane’s remarks: implications for relapse

Viewing 3 posts - 76 through 78 (of 78 total)
1 2 3 4 5 6
  • Author
    Posts
  • 30 April 2016 at 7:03 am #16407
    Avatar photoGreedfighter
    • Guardian Angel
    • ★★★★★
    @greedfighter

    That is the question. Gane should prove Gilead is superior, since that seems to be what he implied.

    30 April 2016 at 8:53 am #16420
    Asif Mostafa
    • Topics: 1
    • Replies: 2
    • Total: 3
    • Novice
    • ★
    @asif-mostafa

    Hello, this is Asif from Incepta.

    We use 1:1 solid dispersion of Ledipasvir with Copovidone where Ledipasvir is in the amorphous form. This is exactly same as that of the innovator. We don’t make our API, we source it from China.

    I wouldn’t say our drug provides 100% success rate, no drug does. But we know a number of patients achieving SVR 12 with Twinvir.

    Asif Mostafa
    M. Pharm (DU), MBA (IBA)
    Senior Brand Manager
    Incepta Pharmaceuticals Ltd.
    40 Shahid Tajuddin Sharani,Tejgaon 1/A, Dhaka-1208
    Phone:8891688-703 (Ex. 155)
    Fax: +880-2-8891190
    Mobile: +88-01713-338492
    Available at Viber and whatsapp
    E-mail: amostafa@inceptapharma.com

    30 April 2016 at 6:34 pm #16444
    Avatar photomgalbrai
    • Guardian Angel
    • ★★★★★
    @mgalbrai

    I imagine Gilead sources from China as well. They want to make as much money as possible and if “Made in China” works for them…..
    I think the main Gane refrain is “The Gilead ledipasvir is real. I can’t say the same about all ledipasvir.”
    m

    Curehcvnow@gmail.com
    http://forums.delphiforums.com/generichcvtx

    G 1a F-1
    Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil
    11/17/15 4 wk lab ALT 17 AST 16 <15
    11/18/15 Started Harvoni
    12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND
    1/14/16 Fin. Tx
    7/07/16 UND SVR 24

  • Author
    Posts
Viewing 3 posts - 76 through 78 (of 78 total)
1 2 3 4 5 6
  • You must be logged in to reply to this topic.